一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

What is Glucagon?

Sep 25,2023

Origin

Following the discovery of insulin by Banting and Best in 1921, a need arose for low-cost methods to rapidly isolate safe preparations of insulin from the pancreas. After that, in 1920, Kimball and Mullin isolated a substance from the pancreas and found that it could induce high blood sugar in dogs and rabbits. In 1923, Kimball and Murlin reported that identified a substance in pancreatic extracts that caused hyperglycaemia, which they named glucagon. Glucagon is the existence of a pancreatic factor other than insulin with effects on glucose homeostasis (GLUCose-AGONist)[1].

Glucagon

Physiological effect

Glucagon is a peptide of 29 amino acids with a variety of biological actions including, but not limited to, glucose homeostasis. It could stimulate glycogenolysis and gluconeogenesis and thus act in opposition to the glucose-lowering effects of insulin. Its physiological effects are very interesting. Glucagon receptor antagonism reduces blood glucose in patients with type 2 diabetes, and glucagon co-agonism (with, e.g., an incretin hormone) reduces body weight in overweight type 2 diabetes patients[2]. Since antagonizing its actions affects fasting but not postprandial blood glucose levels, glucagon ? diabetogenic effect is relatively high.

Glucagon is secreted in response to a variety of metabolic signals such as changes in blood glucose concentrations, certain amino acids, perhaps free fatty acids, and in response to stress (e.g., activation of the sympathetic nervous system). In humans, blood glucose levels are reciprocally correlated to glucagon secretion. Nowadays, exogenous glucagon is used to treat severe hypoglycaemia in T1DM. Not all individuals with T2DM have fasting hyperglucagonaemia, and some individuals with obesity and normal glucose tolerance have hyperglucagonaemia.

Limitation

A major limitation to the study of glucagon physiology and pathophysiology has been the hitherto limited accuracy of many immunoassays used to measure glucagon[3]. Falsely increased glucagon immunoreactivity may be due to degradation of circulating glucagon-containing molecules. Another explanation may be insufficient specificity. Therefore, the term hyperglucagonemia may not in all cases relate to increased plasma concentrations of bioactive glucagon but may as well be ascribed to preanalytical and analytical challenges.

References

[1] A century of glucagon. Nature Reviews Endocrinology, 2023; 19: 311.

[2] Janah, et al. Glucagon Receptor Signaling and Glucagon Resistance. International Journal of Molecular Sciences, 2019; 20.

[3] Sélley E, et al. Vasodilator Effect of Glucagon: Receptorial Crosstalk Among Glucagon, GLP-1, and Receptor for Glucagon and GLP-1. Hormone and Metabolic Research, 2016; 48: 476-483.

  • Related articles
  • Related Qustion
See also
4

Neomycin sulfate is a commonly used antibiotic but is toxic to environmental life and human health, so it is important to detect the concentration of Neomycin sulfate in living organisms and water resources.....

Sep 25,2023API
4

1-Phenyl-2-nitropropene is a versatile compound with potential applications in organic synthesis and medicine, but requires careful handling and storage due to its harmful and irritant effects.....

Sep 26,2023API

Glucagon

16941-32-5

Glucagon manufacturers

  • Glucagon
  • 16941-32-5 Glucagon
  • 2026-06-27
  • CAS:16941-32-5
  • Min. Order: 1g
  • Purity: 98%min
  • Supply Ability: 1000g
  • Glucagon
  • 16941-32-5 Glucagon
  • 2026-06-23
  • CAS:16941-32-5
  • Min. Order: 1g
  • Purity: 0.99
  • Supply Ability: 1000kg

武功县| 绥阳县| 东方市| 西畴县| 北宁市| 尚志市| 舞钢市| 郁南县| 宣汉县| 永平县| 清涧县| 称多县| 中西区| 郁南县| 辽宁省| 健康| 屏东市| 萨迦县| 林口县| 渭南市| 慈溪市| 丰宁| 高淳县| 微博| 正阳县| 正镶白旗| 吴忠市| 白玉县| 佛教| 淮北市| 海南省| 郯城县| 墨脱县| 涪陵区| 汕尾市| 泾川县| 临潭县| 黄石市| 平塘县| 玉门市| 兰考县|